Immune molecule links COVID‑19 with severe inflammatory disorder in children
The immune molecule TGFβ has been found to weaken immune defences against latent viruses, triggering reactivation of the Epstein–Barr virus. This mechanism links TGFβ release in SARS-CoV-2 infection to multisystem inflammatory syndrome in children, and could inform the development of therapies for managing this serious condition. The molecule TGFβ suppresses the ability of T cells to protect against latent Epstein–Barr virus.
Publication Details
- Journal
- Nature
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1038/d41586-025-00735-7
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00